Envestnet Asset Management Inc. trimmed its holdings in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 7.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 56,213 shares of the technology company’s stock after selling 4,200 shares during the period. Envestnet Asset Management Inc.’s holdings in Plexus were worth $8,133,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the business. American Century Companies Inc. grew its position in shares of Plexus by 12.9% during the 2nd quarter. American Century Companies Inc. now owns 765,773 shares of the technology company’s stock valued at $103,617,000 after buying an additional 87,551 shares during the last quarter. Qube Research & Technologies Ltd grew its holdings in shares of Plexus by 37.1% during the second quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock valued at $32,843,000 after purchasing an additional 65,644 shares during the last quarter. Bank of America Corp DE raised its position in shares of Plexus by 53.6% during the 2nd quarter. Bank of America Corp DE now owns 177,237 shares of the technology company’s stock worth $23,982,000 after purchasing an additional 61,817 shares during the period. Cubist Systematic Strategies LLC lifted its holdings in shares of Plexus by 73.3% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 109,943 shares of the technology company’s stock worth $14,876,000 after purchasing an additional 46,513 shares during the last quarter. Finally, Nicola Wealth Management LTD. bought a new stake in Plexus in the third quarter valued at $6,655,000. 94.45% of the stock is currently owned by institutional investors.
Plexus Stock Performance
Shares of PLXS opened at $196.57 on Friday. The company’s 50 day moving average price is $174.70 and its 200 day moving average price is $152.80. The company has a market capitalization of $5.27 billion, a PE ratio of 30.57 and a beta of 0.81. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $211.84. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59.
Insider Activity at Plexus
In related news, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $203.06, for a total value of $873,767.18. Following the transaction, the chief accounting officer owned 20,099 shares in the company, valued at approximately $4,081,302.94. This represents a 17.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Patrick John Jermain sold 2,321 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $201.12, for a total transaction of $466,799.52. Following the transaction, the chief financial officer owned 14,561 shares in the company, valued at approximately $2,928,508.32. This trade represents a 13.75% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 51,669 shares of company stock worth $10,220,816. 1.78% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on PLXS. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Stifel Nicolaus boosted their target price on Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a report on Friday, January 30th. Needham & Company LLC upped their price target on shares of Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a report on Friday, January 30th. Williams Trading set a $195.00 price target on Plexus in a report on Wednesday, January 28th. Finally, Benchmark increased their price objective on Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Plexus currently has an average rating of “Moderate Buy” and a consensus target price of $189.20.
Get Our Latest Report on Plexus
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Recommended Stories
- Five stocks we like better than Plexus
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
